image
Healthcare - Biotechnology - NASDAQ - US
$ 5.065
5.9 %
$ 665 M
Market Cap
-2.57
P/E
Price Target Average
240.57%
Revenue Forecast Estimate
81.96%
EBIT Estimate
19.79%
Net Income Estimate
10.78%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Prime Medicine, Inc.
image
Wall Street analysts predict an average 1-year price target for PRME of $17.2 , with forecasts ranging from a low of $12 to a high of $23 .
PRME Lowest Price Target Wall Street Target
12 USD 136.92%
PRME Average Price Target Wall Street Target
17.2 USD 240.57%
PRME Highest Price Target Wall Street Target
23 USD 354.10%
Price
Max Price Target
Min Price Target
Average Price Target
25252020151510105500Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart PRME

image
$35.0m$35.0m$30.0m$30.0m$25.0m$25.0m$20.0m$20.0m$15.0m$15.0m$10.0m$10.0m$5.0m$5.0m$0.0$0.02022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart PRME

image
$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)2022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart PRME

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)2022202220232023202420242025202520262026202720272028202820292029